Luminex and other multiplex high throughput technologies for the identification of, and host response to, environmental triggers of type 1 diabetes

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Purohit, Sharad ^a   Sharma, Ashok ^a   She, Jin Xiong ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN SPECIFICITY; AUTOIMMUNITY; CHEMOLUMINESCENCE; CROSS REACTION; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL TECHNOLOGY; POLLUTANT; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; ANIMAL; CHEMISTRY; DIABETES MELLITUS, TYPE 1; DISEASE MODEL; HIGH THROUGHPUT SCREENING; METABOLISM; PROCEDURES;

CYTOKINE; PLASMA PROTEIN;

ANIMALS; BLOOD PROTEINS; CYTOKINES; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ENVIRONMENTAL EXPOSURE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; RADIOIMMUNOASSAY;

EID: 84926630289     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/326918     Document Type: Review

References (49)

1. P. Achenbach, E. Bonifacio, K. Koczwara, and A.-G. Ziegler, "Natural history of type 1 diabetes, " Diabetes, vol. 54, supplement 2, pp. S25-S31, 2005.
2. F. M. Egro, "Why is type 1 diabetes increasing?" Journal of Molecular Endocrinology, vol. 51, no. 1, pp. R1-R13, 2013.
3. V. Harjutsalo, T. Podar, and J. Tuomilehto, "Cumulative incidence of type 1 diabetes in 10, 168 siblings of finnish young-onset type 1 diabetic patients, " Diabetes, vol. 54, no. 2, pp. 563-569, 2005.
4. H. K. Akerblom, S. M. Virtanen, J. Ilonen et al., "Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study, " Diabetologia, vol. 48, no. 5, pp. 829-837, 2005.
5. M. Knip, S. M. Virtanen, K. Seppa et al., "Dietary intervention in infancy and later signs of beta-cell autoimmunity, " The New England Journal of Medicine, vol. 363, no. 20, pp. 1900-1908, 2010.
6. L. Ghazarian, J. Diana, Y. Simoni, L. Beaudoin, and A. Lehuen, "Prevention or acceleration of type 1 diabetes by viruses, " Cellular and Molecular Life Sciences, vol. 70, no. 2, pp. 239-255, 2013.
7. L. Galleri, G. Sebastiani, F. Vendrame, F. A. Grieco, I. Spagnuolo, and F. Dotta, "Viral infections and diabetes, " Advances in Experimental Medicine and Biology, vol. 771, pp. 252-271, 2012.
8. J.-W. Yoon and H.-S. Jun, "Role of viruses in the pathogenesis of type 1 diabetesmellitus, " in DiabetesMellitus: A Fundamental andClinical Text, D. LeRoith, S. I. Taylor, and J. M. Olefsky, Eds., LippincottWilliams & Wilkins, Philadephia, Pa, USA, 2004.
9. N. van der Werf, F. G. M. Kroese, J. Rozing, and J.-L. Hillebrands, "Viral infections as potential triggers of type 1 diabetes, " Diabetes/Metabolism Research and Reviews, vol. 23, no. 3, pp. 169-183, 2007.
10. A. Mercalli, V. Lampasona, K. Klingel et al., "No evidence of enteroviruses in the intestine of patients with type 1 diabetes, " Diabetologia, vol. 55, no. 9, pp. 2479-2488, 2012.
11. S. Tracy, K. M. Drescher, J. D. Jackson, K. Kim, and K. Kono, "Enteroviruses, type 1 diabetes and hygiene: a complex relationship, " Reviews in Medical Virology, vol. 20, no. 2, pp. 106-116, 2010.
12. A. Cooke, "Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes?" Immunology, vol. 126, no. 1, pp. 12-17, 2009.
13. J. Ludvigsson, B.-M. Holmqvist, and U. Samuelsson, "Does modern high standard life style cause type 1 diabetes in children?" Diabetes/Metabolism Research and Reviews, vol. 29, no. 2, pp. 161-165, 2013.
14. M. Knip, R. Veijola, S. M. Virtanen, H. Hyoty, O. Vaarala, and H. K. Akerblom, "Environmental triggers and determinants of type 1 diabetes, " Diabetes, vol. 54, no. 2, pp. S125-S136, 2005.
15. C. V. Harinarayan, "Vitamin D and diabetes mellitus, " Hormones, vol. 13, no. 2, pp. 163-181, 2014.
16. M. Knip and O. Simell, "Environmental triggers of type 1 diabetes, " Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 7, Article IDa007690, 2012.
17. J. G. B. Alves, J. N. Figueiroa, J. Meneses, and G. V. Alves, "Breastfeeding protects against type 1 diabetes mellitus: a casesibling study, " Breastfeeding Medicine, vol. 7, no. 1, pp. 25-28, 2012.
18. P. F. Pereira, R. D. C. G. Alfenas, and R. M. A. Araujo, "Does breastfeeding influence the risk of developing diabetes mellitus in children? A review of current evidence, " Jornal de Pediatria, vol. 90, no. 1, pp. 7-15, 2014.
19. I. Thorsdottir and A. V. Thorisdottir, "Whole cows milk in early life, " Nestle NutrWorkshop Ser Pediatr Program, vol. 67, pp. 29-40, 2011.
20. J. M. Norris, "Infant and childhood diet and type 1 diabetes risk: recent advances and prospects, " Current Diabetes Reports, vol. 10, no. 5, pp. 345-349, 2010.
21. M. Pflueger, T. Seppanen-Laakso, T. Suortti et al., "Age-and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes, " Diabetes, vol. 60, no. 11, pp. 2740-2747, 2011.
22. O. Vaarala, "Leaking gut in type 1 diabetes, " Current Opinion in Gastroenterology, vol. 24, no. 6, pp. 701-706, 2008.
23. O. Vaarala, M. A. Atkinson, and J. Neu, "The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, andmucosal immunity, " Diabetes, vol. 57, no. 10, pp. 2555-2562, 2008.
24. S. Tracy, K. M. Drescher, and N. M. Chapman, "Enteroviruses and type 1 diabetes, "Diabetes/MetabolismResearch and Reviews, vol. 27, no. 8, pp. 820-823, 2011.
25. C. M. Filippi and M. G. von Herrath, "Viral trigger for type 1 diabetes: pros and cons, " Diabetes, vol. 57, no. 11, pp. 2863-2871, 2008.
26. C. Bason, R. Lorini, C. Lunardi et al., "In type 1 diabetes a subset of anti-coxsackievirus B4 antibodies recognize autoantigens and induce apoptosis of pancreatic beta cells, " PLoS ONE, vol. 8, no. 2, Article ID e57729, 2013.
27. Z. M. I. Dezayee, "The status of serum -interferonand antiviral antibodies in patients with type I and type 2 diabetes: a comparative study, " Journal of Research inMedical Sciences, vol. 17, no. 9, pp. 855-858, 2012.
28. C. Carey, S. Purohit, and J.-X. She, "Advances and challenges in biomarker development for type 1 diabetes prediction and prevention using "omic" technologies, " Expert Opinion on Medical Diagnostics, vol. 4, no. 5, pp. 397-410, 2010.
29. C. D. Collins, S. Purohit, R. H. Podolsky et al., "The application of genomic and proteomic technologies in predictive, preventive and personalized medicine, " Vascular Pharmacology, vol. 45, no. 5, pp. 258-267, 2006.
30. S. Purohit, R. Podolsky, D. Schatz et al., "Assessing the utility of SELDI-TOF and model averaging for serum proteomic biomarker discovery, " Proteomics, vol. 6, no. 24, pp. 6405-6415, 2006.
31. S. Purohit and J. X. She, "Biomarkers for type 1 diabetes, " International Journal of Clinical and ExperimentalMedicine, vol. 1, no. 2, pp. 98-116, 2008.
32. W. Zhi, S. Purohit, C. Carey, M. Wang, and J.-X. She, "Proteomic technologies for the discovery of type 1 diabetes biomarkers, " Journal of Diabetes Science andTechnology, vol. 4, no. 4, pp. 993-1002, 2010.
33. W. Sakly, A. Manka, N. Sakly et al., "Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes, " Endocrine Pathology, vol. 21, no. 2, pp. 108-114, 2010.
34. M. Simpson, M. Mojibian, K. Barriga et al., "An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus, " Pediatric Diabetes, vol. 10, no. 8, pp. 563-572, 2009.
35. A. J. MacFarlane, K. M. Burghardt, J. Kelly et al., "A type 1 diabetes-related protein fromwheat (Triticum aestivum): cDNA clone of a wheat storage globulin, Glb1, linked to islet damage, " The Journal of Biological Chemistry, vol. 278, no. 1, pp. 54-63, 2003.
36. R. Troncone, A. Franzese, G. Mazzarella et al., "Gluten sensitivity in a subset of children with insulin dependent diabetes mellitus, "The American Journal of Gastroenterology, vol. 98, no. 3, pp. 590-595, 2003.
37. K. Adler, D. B. Mueller, P. Achenbach et al., "Insulin autoantibodies with high affinity to the bovine milk protein alpha casein, " Clinical and Experimental Immunology, vol. 164, no. 1, pp. 42-49, 2011.
38. A. Giongo, K. A. Gano, D. B. Crabb et al., "Toward defining the autoimmune microbiome for type 1 diabetes, " ISMEJournal, vol. 5, no. 1, pp. 82-91, 2011.
39. K. Salminen, K. Sadeharju, M. Lonnrot et al., "Enterovirus infections are associated with the induction of -cell autoimmunity in a prospective birth cohort study, " Journal of Medical Virology, vol. 69, no. 1, pp. 91-98, 2003.
40. S. X. Leng, J. E. McElhaney, J. D. Walston, D. Xie, N. S. Fedarko, and G. A. Kuchel, "ELISA and multiplex technologies for cytokinemeasurement in inflammation and aging research, " Journals of Gerontology A: Biological Sciences and Medical Sciences, vol. 63, no. 8, pp. 879-884, 2008.
41. J. Yu, J. Lin, K.-H. Kim, W. H. Benjamin Jr., and M. H. Nahm, "Development of an automated and multiplexed serotyping assay for Streptococcus pneumoniae, " Clinical and Vaccine Immunology, vol. 18, no. 11, pp. 1900-1907, 2011.
42. H. Croft, T. Malinowski, L. Krizbai et al., "Use of Luminex xMAP-derived Bio-Plex bead-based suspension array for specific detection of PPV W and characterization of epitopes on the coat protein of the virus, " Journal of Virological Methods, vol. 153, no. 2, pp. 203-213, 2008.
43. S. Anderson, P. Wakeley, G. Wibberley, K. Webster, and J. Sawyer, "Development and evaluation of a Luminex multiplex serology assay to detect antibodies to bovine herpes virus 1, parainfluenza 3 virus, bovine viral diarrhoea virus, and bovine respiratory syncytial virus, with comparison to existing ELISA detectionmethods, " Journal of ImmunologicalMethods, vol. 366, no. 1-2, pp. 79-88, 2011.
44. D. Opalka, C. E. Lachman, S. A. MacMullen et al., "Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay, " Clinical and Diagnostic Laboratory Immunology, vol. 10, no. 1, pp. 108-115, 2003.
45. Y. Liu, Z. Q. Xu, Q. Zhang et al., "Simultaneous detection of seven enteric viruses associated with acute gastroenteritis by a multiplexed luminex-based assay, " Journal of Clinical Microbiology, vol. 50, no. 7, pp. 2384-2389, 2012.
46. S. Takao, M. Hara, T. Okazaki, and K. Suzuki, "Simultaneous multiple assay (Luminex xTAG respiratory viral panel FAST assay) efficacy in human respiratory virus detection, " Kansenshogaku Zasshi, vol. 85, no. 1, pp. 31-36, 2011.
47. W. Zhi, A. Sharma, S. Purohit et al., "Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatographymass spectrometry and immunoassays, "Molecular and Cellular Proteomics, vol. 10, no. 11, 2011.
48. R. Guan, S. Purohit, H. Wang et al., "Chemokine (c-c motif) ligand 2 (ccl2) in sera of patients with type 1 diabetes and diabetic complications, " PLoS ONE, vol. 6, no. 4, Article ID e17822, 2011.
49. S. Lu, S. Purohit, A. Sharma et al., "Serum insulin-like growth factor binding protein 6 (IGFBP6) is increased in patients with type 1 diabetes and its complications, " International Journal of Clinical and Experimental Medicine, vol. 5, no. 3, pp. 229-237, 2012.